Hyperplastic polyps and colorectal cancer: Is there a link?

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 1, 2004, Pages 1-8

  Jass, Jeremy R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Duff Medical Building ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

STOMACH MUCIN; TREFOIL PEPTIDE;

ADENOMA; ANOIKIS; APOPTOSIS; BASE MISPAIRING; CANCER RISK; CELL STRUCTURE; CHROMOSOME REARRANGEMENT; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; DISEASE CLASSIFICATION; DNA METHYLATION; EPITHELIUM HYPERPLASIA; FOLLOW UP; GENE MUTATION; HUMAN; INTESTINE EPITHELIUM; MEDICAL EXAMINATION; MICRODISSECTION; MICROSATELLITE INSTABILITY; REVIEW; SIGNAL TRANSDUCTION;

ADENOMA; COLORECTAL NEOPLASMS; HUMANS; HYPERPLASIA; INTESTINAL POLYPS;

EID: 0842329668     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)00284-2     Document Type: Review

References (98)

1. Morson B.C., Bussey H.J.R., Day D.W., Hill M.J. Adenomas of the large bowel. Cancer Surv. 2:1983;451-477.
2. Winawer S.J., Fletcher R.H., Miller L., Godlee F., Stolar M.H., Mulrow C.D., Woolf S.H., Glick S.N., Ganiats T.G., Bond J.H., Rosen L., Zapka J.G., Olsen S.J., Giardiello F.M., Sisk J.E., Van Antwerp R., Brown-Davis C., Marciniak D.A., Mayer R.J. Colorectal cancer screening clinical guidelines and rationale . Gastroenterology. 112:1997;594-642.
3. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M.M., Bos J.L. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532.
4. Kronborg O., Fenger C. Clinical evidence for the adenoma-carcinoma sequence. Eur J Cancer Prev. 8:1999;S73-S86.
5. Jass J.R., Whitehall V.L.J., Young J., Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology. 123:2002;862-876.
6. Konishi F., Morson B.C. Pathology of colorectal adenomas a colonoscopic survey . J Clin Pathol. 35:1982;830-841.
7. Muto T., Bussey H.J.R., Morson B.C. The evolution of cancer of the rectum. Cancer. 36:1975;2251-2276.
8. Jen J., Powell S.M., Papadopoulos N., Smith K.J., Hamilton S.R., Vogelstein B., Kinzler K.W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54:1994;5523-5526.
9. Morson B.C. Some peculiarities in the histology of intestinal polyps. Dis Colon Rectum. 5:1962;337-344.
10. Arthur J.F. Structure and significance of metaplastic nodules in the rectal mucosa. J Clin Pathol. 21:1968;735-743.
11. Hayashi T., Yatani R., Apostol J., Stemmermann G.N. Pathogenesis of hyperplastic polyps of the colon a hypothesis based on ultrastructure and in vitro cell kinetics . Gastroenterology. 66:1974;347-356.
12. Kaye G.I., Fenoglio C.M., Pascal R.R., Lane N. Comparative electron microscopic features of normal, hyperplastic, and adenomatous human colonic epithelium variations in cellular structure relative to the process of epithelial differentiation . Gastroenterology. 64:1973;926-945.
13. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 124:1994;619-626.
14. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr Opin Cell Biol. 3:2001;555-562.
15. Shanmugathasan M., Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int. 50:2000;273-279.
16. Otori K., Oda Y., Sugiyama K., Hasebe T., Mukai K., Fujii T., Tajiri H., Yoshida S., Fukushima S., Esumi H. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut. 40:1997;660-663.
17. Fenton R.G., Hixon J.A., Wright P.W., Brooks A.D., Sayers T.J. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res. 58:1998;3391-3400.
18. Tateyama H., Li W., Takahashi E., Miura Y., Sugiura H., Eimoto T. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum the saw-toothed structure may be related to inhibition of apoptosis . Am J Surg Pathol. 26:2002;249-256.
19. Jacks T., Weinberg R.A. Taking the study of cancer cell survival to a new dimension. Cell. 111:2002;923-925.
20. Jass J.R., Young J., Leggett B.A. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology. 37:2000;295-301.
21. Wasan H.S., Park H.-S., Liu K.C., Mandir N., Goodlad R.A., Wong B.C.Y., Garcia S.B., Lam S.-K., Wright N.A. APC in the regulation of intestinal crypt fission. J Pathol. 185:1998;246-255.
22. Wong W.-M., Mandir N., Goodlad R.A., Wong B.C.Y., Garcia S.B., Lam S.-K., Wright N.A. Histogenesis of human colorectal adenomas and hyperplastic polyps the role of cell proliferation and crypt fission . Gut. 50:2002;212-217.
23. Jass J.R., Strudley I., Faludy J. Histochemistry of epithelial metaplasia and dysplasia in human stomach and colon. Scand J Gastroenterol. 19:(suppl 104):1984;109-130.
24. Jass J.R., Faludy J. Immunohistochemical demonstration of IgA and secretory component in relation to epithelial cell differentiation in normal colorectal mucosa and metaplastic polyp a semiquantitative study . Histochem J. 17:1985;373-380.
25. Jass J.R., Filipe M.I., Abbas S., Falcon C.A., Wilson Y., Lovell D. A morphologic and histochemical study of metaplastic polyps of the colorectum. Cancer. 53:1984;510-515.
26. Hanby A.M., Poulsom R., Singh S., Jankowski J., Hopwood D., Elia G., Rogers L., Patel K., Wright N.A. Hyperplastic polyps a cell lineage which both synthesizes and secretes trefoil peptides and has phenotypic similarity with the ulcer-associated cell lineage . Am J Pathol. 142:1993;663-668.
27. Biemer-Hüttmann A.-E., Walsh M.D., McGuckin M.A., Ajioka Y., Watanabe H., Leggett B.A., Jass J.R. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem. 47:1999;1039-1047.
28. Koike M., Inada K., Nakanishi H., Matsuura A., Nakamura S., Tatematsu M. Cellular differentiation status of epithelial polyps of the colorectum the gastric fovelar cell-type in hyperplastic polyps . Histopathology. 42:2003;357-364.
29. Czernobilsky B., Tsou K.C. Adenocarcinoma, adenomas and polyps of the colorectum. Cancer. 21:1968;165-177.
30. Jass J.R. Relation between metaplastic polyp and carcinoma of the colorectum. Lancet. i:1983;28-30.
31. Opelka F.G., Timmincke A.E., Gathright J.B. Jr. Diminutive colonic polyps an indication for colonoscopy . Dis Colon Rectum. 35:1992;178-181.
32. Warner A.S., Glick M.E., Fogt F. Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol. 89:1994;123-125.
33. Cooper H.S., Patchefsky A.S., Marks G. Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum. 22:1979;152-156.
34. Urbanski S.J., Marcon N., Kossakowska A.E., Bruce W.R. Mixed hyperplastic adenomatous polyps an underdiagnosed entity - report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp . Am J Surg Pathol. 8:1984;551-556.
35. Franzin G., Novelli P. Adenocarcinoma occurring in a hyperplastic (metaplastic) polyp of the colon. Endoscopy. 14:1982;28-30.
36. Jass J.R., Young P.J., Robinson E.M. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas a necropsy study in New Zealand . Gut. 33:1992;1508-1514.
37. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., Ransohoff D.F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 343:2000;169-174.
38. Rex D.K., Smith J.J., Ulbright T.M., Lehman G.A. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology. 102:1992;317-319.
39. Huang E.H., Whelan R.L., Gleason N.R., Maeda J.S., Terry M.B., Lee S.W., Neugut N.I., Forde K.A. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps. Surg Endosc. 15:2001;646-648.
40. Martínez M.E., McPherson R.S., Levin B., Glober G.A. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 113:1997;423-429.
41. Morimoto L.M., Newcomb P.A., Ulrich C.M., Bostick R.M., Lais C.J., Potter J.D. Risk factors for hyperplastic and adenomatous polyps evidence for malignant potential . Cancer Epidemiol Biomarkers Prev. 11:2002;1012-1018.
42. Slattery M.L., Curtin K., Anderson K., Ma K.N., Ballard L., Edwards S., Schaffer D., Potter J., Leppert M., Samowitz W.S. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 92:2000;1831-1836.
43. Burt R.W., Jass J.R. Hyperplastic polyposis. Hamilton S.R., Aaltonen L.A. WHO classification of tumours: pathology and genetics: tumours of the digestive system. 2000;Springer-Verlag, Berlin.
44. Williams G.T., Arthur J.F., Bussey H.J.R., Morson B.C. Metaplastic polyps and polyposis of the colorectum. Histopathology. 4:1980;155-170.
45. Spjut H.J., Estrada R.G. The significance of epithelial polyps of the large bowel. Pathol Ann. 12:1977;147-170.
46. Sumner H.W., Wasserman N.F., McClain C.J. Giant hyperplastic polyposis of the colon. Dig Dis Sci. 26:1981;85-89.
47. Bengoechea O., Martinez-Penuela J.M., Larrinaga B., Borda F. Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24 year old man. Am J Surg Pathol. 11:1987;323-327.
48. McCann B.G. A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas. Histopathology. 13:1988;700-702.
49. Teoh H.H., Delahunt B., Isbister W.H. Dysplastic and malignant areas in hyperplastic polyps of the large intestine. Pathology. 21:1989;138-142.
50. Jeevaratnam P., Cottier D.S., Browett P.J., Van de Water N.S., Pokos V., Jass J.R. Familial giant hyperplastic polyposis predisposing to colorectal cancer a new hereditary bowel cancer syndrome . J Pathol. 179:1996;20-25.
51. Jass J.R., Iino H., Ruszkiewicz A., Painter D., Solomon M.J., Koorey D.J., Cohn D., Furlong K., Walsh M.D. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 47:2000;43-49.
52. Leggett B.A., Devereaux B., Biden K., Searle J., Young J., Jass J. Hyperplastic polyposis association with colorectal cancer . Am J Surg Pathol. 25:2001;177-184.
53. Rashid A., Houlihan S., Booker S., Petersen G.M., Giardiello F.M., Hamilton S.R. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology. 119:2000;323-332.
54. Renault A.J., Douglas P.R., Newstead G.L. Hyperplastic polyposis of the colon and rectum. Colorect Dis. 4:2002;213-215.
55. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., Srivastava S. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition development of international criteria for the determination of microsatellite instability in CRC . Cancer Res. 58:1998;5248-5257.
56. Longacre T.A., Fenoglio-Preiser C.M. Mixed hyperplastic adenomatous polyps/serrated adenomas a distinct form of colorectal neoplasia . Am J Surg Pathol. 14:1990;524-537.
57. Iino H., Jass J.R., Simms L.A., Young J., Leggett B., Ajioka Y., Watanabe H. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps a mild mutator pathway for colorectal cancer? J Clin Pathol. 52:1999;5-9.
58. Jass J.R. Serrated route to colorectal cancer back street or super highway? J Pathol. 193:2001;283-285.
59. Jass J.R. Serrated adenoma of the colorectum. Curr Diag Pathol. 8:2002;42-49.
60. Torlakovic E., Skovlund E., Snover D.C., Torlakovic G., Nesland J.M. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 27:2003;65-81.
61. Williams G.T. Metaplastic (hyperplastic) polyps of the large bowel benign neoplasms after all? Gut. 40:1997;691-692.
62. Yuen S.T., Davies H., Chan T.L., Ho J.W., Bignell G.R., Cox C., Stephens P., Edkins S., Tsui W.W., Chan A.S., Futreal A., Stratton M.R., Wooster R., Leung S.Y. Similarity of the phenotypic patterns associated with BRAF and K-ras mutations in colorectal cancer. Cancer Res. 62:2002;6451-6455.
63. Konishi M., Kikuchi-Yanoshita R., Tanaka K., Muraoka M., Onda A., Okumura Y., Kishi N., Iwama T., Mori T., Koike M., Ushio K., Chiba M., Nomizu S., Konishi F., Utsunumiya J., Miyaki M. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology. 111:1996;307-317.
64. Bomme L., Bardi G., Pandis N., Fenger C., Kronborg O., Heim S. Clonal karyotypic abnormalities in colorectal adenomas clues to the early genetic events in the adenoma-carcinoma sequence . Genes Chromosomes Cancer. 10:1994;190-196.
65. Clebanoff J.L., Yang S., Mulcahy E., Farraye F., Amorosini M., Swan N., O'Brien M.J. A study of CpG island methylator phenotype (CIMP) and K-ras mutation in sporadic hyperplastic polyps of the proximal and distal colorectum. Mod Pathol. 16:2003;116A.
66. Hawkins N.J., Gorman P., Tomlinson I.P.M., Bullpitt P., Ward R.L. Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway. Am J Pathol. 157:2000;385-392.
67. Chan A.O.-O., Issa J.-P.J., Morris J.S., Hamilton S.R., Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 160:2002;529-536.
68. Torlakovic E., Snover D.C. Serrated adenomatous polyposis in humans. Gastroenterology. 110:1996;748-755.
69. Jass J.R. Hyperplastic-like polyps as precursors of microsatellite unstable colorectal cancer. Am J Clin Pathol. 119:2003;773-775.
70. Goldstein N.S., Bhanot P., Odish E., Hunter S. Hyperplastic-like colon polyps that preceded microsatellite unstable adenocarcinomas. Am J Clin Pathol. 119:2003;778-796.
71. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
72. Grady W.M., Rajput A., Myeroff L., Liu D.F., Kwon K., Willis J., Markowitz S. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 58:1998;3101-3104.
73. Ricciardiello L., Goel A., Mantovani V., Fiorini T., Fossi S., Chang D.K., Lunedei V., Pozzato P., Zagari R.M., De Luca L., Fuccio L., Martinelli G.N., Roda E., Boland C.R., Bazzoli F. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatelite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res. 63:2003;787-792.
74. Loukola A., Salovaara R., Kristo P., Moisio A.-L., Kääriä inen H., Ahtola H., Eskelinen M., Härkönen N., Julkunen R., Kangas E., Ojala S., Tulikoura J., Valkamo E., Järvinen H., Mecklin J.-P., de la Chapelle A., Aaltonen L.A. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol. 155:1999;1849-1853.
75. Olschwang S., Hamelin R., Laurent-Puig P., Thuille B., De Rycke Y., Li Y.J., Muzeau F., Girodet J., Salmon R.J., Thomas G. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A. 94:1997;12122-12127.
76. Salahshor S., Kressner U., Påhlman L., Glimelius B., Lindmark G., Lindblom A. Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer. 26:1999;247-252.
77. Aaltonen L.A., Peltomäki P.S., Leach F.S., Sistonen P., Pylkkänen L., Mecklin J.-P., Järvinen H., Powell S.M., Jen J., Hamilton S.R., Petersen G.M., Kinzler K.W., Vogelstein B. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
78. Homfray T.F., Cottrell S.E., Ilyas M., Rowan A., Talbot I.C., Bodmer W.F., Tomlinson I.P. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutat. 11:1998;114-120.
79. Rajagopalan H., Bardelli A., Lengauer C., Kinzler K.W., Vogelstein B., Velculescu V.E. RAF/RAS oncogenes and mismatch-repair status. Nature. 418:2002;934.
80. Wang L., Cunningham J.M., Winters J.L., Guenther J.C., French A.J., Boardman L.A., Burgart L.J., McDonnell S.K., Schaid D.J., Thibodeau S.N. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res. 63:2003;5209-5212.
81. Chan T.L., Zhao W., Leung S.Y., Yuen S.T. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adnomas. Cancer Res. 63:2003;4878-4881.
82. Jass J.R., Young J., Leggett B.A. Biological significance of microsatellite instability-low (MSI-L) status in colorectal tumors. (letter) Am J Pathol. 158:2001;779-780.
83. Biemer-Hüttmann A.-E., Walsh M.D., McGuckin M.A., Young J., Leggett B.A., Jass J.R. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res. 6:2000;1909-1916.
84. Hawkins N.J., Ward R.L. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 93:2001;1307-1313.
85. Mäkinen M.J., George S.M.C., Jernvall P., Mäkelä J., Vihko P., Karttunen T.J. Colorectal carcinoma associated with serrated adenoma prevalence, histological features, and prognosis . J Pathol. 193:2001;286-294.
86. Park S.-J., Rashid A., Lee J.-H., Kim S.G., Hamilton S.R., Wu T.T. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol. 162:2003;815-822.
87. Jass J.R., Young J., Leggett B.A. Evolution of colorectal cancer change of pace and change of direction . J Gastroenterol Hepatol. 17:2002;17-26.
88. Young J.P., Biden K.G., Simms L.A., Karamatic R., Huggard P., Eyre H.E., Sutherland G.R., Herath N., Barker M., Anderson G.J., Fitzpatrick D., Ramm G.A., Jass J.R., Leggett B.A. HPP1 a transmembrane protein commonly methylated in colorectal polyps and cancers . Proc Natl Acad Sci U S A. 98:2001;265-270.
89. Fishel R. Signaling mismatch repair in cancer. Nat Med. 5:1999;1239-1241.
90. Whitehall V.L.J., Wynter C.V.A., Walsh M.D., Simms L.A., Purdie D., Pandeya N., Young J., Meltzer S.J., Leggett B.A., Jass J.R. Morphological and molecular heterogeneity within non-microsatellite instability-high colorectal cancer. Cancer Res. 62:2002;6011-6014.
91. Whitehall V.L.J., Walsh M.D., Young J., Leggett B.A., Jass J.R. Methylation of 0-6-methylguanine DNA methyltransferase characterises a subset of colorectal cancer with low level DNA microsatellite instability. Cancer Res. 61:2001;827-830.
92. Sawyer E.J., Cerar A., Hanby A.M., Gorman P., Arends M., Talbot I.C., Tomlinson I.P. Molecular characteristics of serrated adenomas. Gut. 51:2002;200-206.
93. Hawkins N., Norrie M., Cheong K., Mokany E., Ku S.-L., Meagher A., O'Connor T., Ward R. CpG island methylation in sporadic colorectal cancer and its relationship to microsatellite instability. Gastroenterology. 122:2002;1376-1387.
94. Rashid A., Shen L., Morris J.S., Issa J.-.P.J., Hamilton S.R. CpG island methylation in colorectal adenomas. Am J Pathol. 159:2001;1129-1135.
95. Takayama T., Katsuki S., Takahashi Y., Ohio M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 339:1998;1277-1284.
96. Janssen K.-P., El Marjou F., Pinto D., Sastre X., Rouillard D., Fouquet C., Soussi T., Louvard D., Robine S. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology. 123:2002;492-504.
97. Roncucci L., Stamp D., Medline A., Cullen J.B., Bruce W.R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 22:1991;287-294.
98. Nascimbeni R., Villanacci V., Mariani P.P., Di Betta E., Ghirardi M., Donato F., Salerni B. Aberrant crypt foci in the human colon. Am J Surg Pathol. 23:1999;1256-1263.